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isruption of the dystrophin–glycoprotein complex
caused by genetic defects of dystrophin or sarcogly-
cans results in muscular dystrophy and/or cardiomy-
opathy in humans and animal models. However, the key early
molecular events leading to myocyte degeneration remain
elusive. Here, we observed that the growth factor–regulated
channel (GRC), which belongs to the transient receptor
potential channel family, is elevated in the sarcolemma of
skeletal and/or cardiac muscle in dystrophic human patients
 
and animal models deﬁcient in dystrophin or 
 
 
 
-sarcoglycan.
However, total cell GRC does not differ markedly between
normal and dystrophic muscles. Analysis of the properties
of myotubes prepared from 
 
 
 
-sarcoglycan–deﬁcient BIO14.6
D
 
hamsters revealed that GRC is activated in response to
 
myocyte stretch and is responsible for enhanced Ca
 
2
 
 
 
 inﬂux
and resultant cell damage as measured by creatine phos-
phokinase efﬂux. We found that cell stretch increases GRC
translocation to the sarcolemma, which requires entry of
 
external Ca
 
2
 
 
 
. Consistent with these ﬁndings, cardiac-speciﬁc
expression of GRC in a transgenic mouse model produced
cardiomyopathy due to Ca
 
2
 
 
 
 overloading, with disease
expression roughly parallel to sarcolemmal GRC levels.
The results suggest that GRC is a key player in the patho-
genesis of myocyte degeneration caused by dystrophin–
glycoprotein complex disruption.
 
Introduction
 
In striated muscle fibers, dystrophin forms a trans-sarcolemmal
complex with its associated proteins, i.e., the intrinsic mem-
brane glycoproteins 
 
 
 
-dystroglycan and 
 
 
 
-, 
 
 
 
-, 
 
 
 
-, and
 
 
 
-sarcoglycans (
 
 
 
-SGs),* as well as several nonmembrane pro-
teins (Straub and Campbell, 1997; Ozawa et al., 1998). This
large oligomeric composite, named the dystrophin–glycopro-
tein complex (DGC), links the intracellular actin cytoskeleton
 
to the overlying basal lamina, thereby providing structural support
for the sarcolemma. The functional importance of the DGC
is underscored by the fact that genetic defects in its major
components (dystrophin and sarcoglycans) disrupt the com-
plex, leading to muscular dystrophy and/or cardiomyopathy
in humans and animal models (Straub and Campbell, 1997;
Ozawa et al., 1998; Towbin and Bawles, 2002).
The mechanism by which a defective DGC causes myocyte
degeneration still remains elusive. Myocyte degeneration has
long been attributed to membrane defects such as greater
fragility toward mechanical stress (Mokri and Engel, 1975;
Menke and Jockusch, 1991; Petrof et al., 1993) or increased
permeability to Ca
 
2
 
 
 
 (Fong et al., 1990; Tutdibi et al.,
1999; Alderton and Steinhardt, 2000b). A number of studies
have reported chronic elevation of [Ca
 
2
 
 
 
] in the cytosol
([Ca
 
2
 
 
 
]
 
i
 
), beneath the sarcolemma, or within other cell com-
partments in skeletal muscle fibers and cultured myotubes
from dystrophin-deficient Duchenne muscular dystrophy
(DMD) patients and 
 
mdx
 
 mice (a mouse model of DMD;
Brown and Lucy, 1997; Mallouk et al., 2000; Robert et al.,
2001), although elevation of resting [Ca
 
2
 
 
 
]
 
i
 
 has often been
disputed. Enhanced Ca
 
2
 
 
 
 entry into dystrophic myocytes is
consistent with previous demonstrations of sustained activation
of sarcolemmal Ca
 
2
 
 
 
-permeable channels (a Ca
 
2
 
 
 
-specific leak
channel [Fong et al., 1990; Alderton and Steinhardt, 2000b]
or a mechanosensitive nonselective cation channel [Franco-
Obregon and Lansman, 1994; Vandebrouck et al., 2001]).
The BIO14.6 strain of the Syrian hamster develops severe
cardiomyopathy and muscular dystrophy due to a genetic
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defect in its 
 
 
 
-SG, and usually dies of congestive heart failure
(Bajusz et al., 1969; Nigro et al., 1997). In this model, the
DGC is disrupted because 
 
 
 
-SG deficiency causes secondary
reduction of other sarcoglycans and 
 
 
 
-dystroglycan in the
sarcolemma, whereas dystrophin and 
 
 
 
-dystroglycan are still
retained at one half of their normal levels (Iwata et al.,
1993). We have shown in recent work that stretch-sensitive
cation-selective channels similar to those recorded in 
 
mdx
 
skeletal muscle are active in resting cultured myotubes pre-
pared from BIO14.6 hamster (Nakamura et al., 2001).
To identify Ca
 
2
 
 
 
 entry mechanisms possibly responsible
for the pathogenesis of myocyte degeneration, we undertook
a search for mammalian homologues of the 
 
Drosophila
 
 tran-
sient receptor potential (TRP) channel expressed in striated
muscle, because this family of channels contains a subfamily
of Ca
 
2
 
 
 
-permeable cation channels sensitive to physical
stimuli, such as osmotic stress or heat (Montell and Birn-
baumer, 2002). Here, we report that the growth factor–reg-
ulated channel (GRC) belonging to the TRP family (Kan-
zaki et al., 1999) and being possibly a mouse homologue of
VRL1 (Caterina et al., 1999), is abundantly expressed in the
sarcolemma of cardiac or skeletal myocytes with defective
dystrophin or 
 
 
 
-SG. GRC, which was originally identified as
a Ca
 
2
 
 
 
-permeable nonselective cation channel expressed in
nonmuscle cells, localizes mainly in intracellular pools under
basal conditions and translocates to the cell surface on stim-
ulation with growth factors (Kanzaki et al., 1999). Our new
results suggest that GRC is a mechanosensitive channel and
may be involved in the pathogenesis of myocyte degenera-
tion caused by DGC disruption.
 
Results
 
GRC expression in normal and dystrophic 
striated muscles
 
We cloned Ca
 
2
 
 
 
-permeable cation channels structurally re-
lated to a subfamily of TRP channels, VR1 (Caterina et al.,
1997), GRC, and a stretch-inhibitable channel (Suzuki et al.,
1999), by PCR using degenerate primers for their conserved
amino acid sequences. Out of 13 DNA fragments isolated
from mouse heart total RNA, 12 contained the same se-
quence as that of GRC. Furthermore, screening of a mouse
Figure 1. Expression of GRC in dystrophic muscles. (a) Contents of GRC protein in cardiac and skeletal muscles from BIO14.6 hamster, mdx 
mouse, and normal controls. Muscle homogenates (40  g per lane) were subjected to immunoblot assay with anti-GRC. (b and c) Immuno-
histochemical localization of GRC in frozen sections of cardiac and skeletal muscles from normal and dystrophic animals and skeletal muscles 
from dystrophic patients and a nondystrophic control. Bars, 50  m. (d) Immunoblot analysis of skeletal muscle homogenates from dystrophic 
patients and a nondystrophic control using antibodies against the indicated proteins. Samples correspond to those in c. Dys, dystrophin; SG, 
sarcoglycan; DG, dystroglycan; Syn, syntrophin.T
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cDNA library with the PCR product under low stringency
conditions did not permit isolation of other clones related to
TRP channels. Thus, among its homologues, GRC appears
to be the predominant protein expressed in the heart.
We examined the expression of GRC protein in striated
muscles of hamster and mouse. In an immunoblot assay, the
85-kD GRC protein was 
 
 
 
10-fold more abundant in cardiac
than in skeletal muscle (Fig. 1 a). Immunohistochemical
analysis of cardiac muscle revealed that GRC expression was
prominent in the intercalated disc, but much less so in pe-
ripheral sarcolemma and the cell interior (Fig. 1 b). In skele-
tal myocytes, GRC was localized diffusely in the cell interior,
with trace levels in the sarcolemma. Intriguingly, GRC in the
peripheral sarcolemma was significantly elevated in cardiac
and skeletal muscles of BIO14.6 hamsters and skeletal mus-
cle of 
 
mdx
 
 mice compared with their normal counterparts
(Fig. 1 b), although the GRC content did not differ mark-
edly between normal and dystrophic muscles (Fig. 1 a). In
 
mdx
 
 cardiac muscle, the sarcolemmal GRC was not elevated,
which may be compatible with minimal dystrophic changes
in the heart of this model (Torres and Duchen, 1987).
Anti-GRC staining of the sarcolemma was also much in-
creased in skeletal muscles from myopathic patients with ab-
normal DGC. Patient 1 had Becker muscular dystrophy due
to deletion of exons 47 and 48 of the dystrophin gene, and
exhibited reduced expression of most components of the
DGC (Fig. 1 d), although an antidystrophin COOH termi-
nus antibody, Dys-2, was able to stain the sarcolemma (un-
published data). Patients 2 and 3 were diagnosed as having
limb-girdle muscular dystrophy, and exhibited markedly re-
duced expression of 
 
 
 
-, 
 
 
 
-, and 
 
 
 
-SGs; other DGC compo-
nents, including 
 
 
 
-sarcoglycan, were relatively well retained,
except for dystrophin in Patient 2 (Fig. 1 d).
 
Properties of myotubes prepared from BIO14.6 
hamster or 
 
mdx
 
 mouse
 
As in adult skeletal muscle, GRC expression was increased
in the sarcolemma of cultured myotubes prepared from
BIO14.6 hamster or 
 
mdx
 
 mouse, whereas it was present
mostly in the interior of normal myotubes (Fig. 2 a). In the
latter, GRC shifted its location from the cell interior to the
sarcolemma in response to 10 ng/ml IGF-1 (Fig. 2 b) or
Figure 2. GRC translocation in normal and dystrophic myotubes. (a) Immunohistochemical localization of GRC protein in myotubes from 
BIO14.6 hamster and mdx mouse. (b) Effect of IGF-1 treatment or cyclic cell stretch on GRC translocation in normal mouse and hamster 
myotubes. (c) Ca
2 -induced shift of GRC localization in BIO14.6 myotubes. Myotubes initially placed in 2 mM Ca
2  were transferred to 
medium containing 0.5 mM Gd
3 , and 1 h later were transferred back to 2 mM Ca
2 .T
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10% FCS, as is the case in CHO cells (see Fig. 5 a; Kanzaki
et al., 1999). GRC translocation also occurred when we sub-
jected normal hamster myotubes to a cyclic stretch of 20%
elongation for 15 min in 2 mM Ca
 
2
 
 
 
 (Fig. 2 b). However,
IGF-1– or stretch-induced GRC translocation did not occur
in 0.5 mM Gd
 
3
 
 
 
. Interestingly, when we placed BIO14.6
myotubes in Gd
 
3
 
 
 
-containing medium, a slow but pro-
nounced reduction in sarcolemmal GRC occurred (Fig. 2 c).
Re-exposure of BIO myotubes to 2 mM Ca
 
2
 
 
 
 resulted in the
reappearance of GRC in the sarcolemma within 15 min.
Unlike translocation induced by IGF-1 (Kanzaki et al.,
1999), PI-3 kinase inhibitors (wortmannin or LY294002)
did not inhibit this Ca
 
2
 
 
 
-induced translocation. Thus, Ca
 
2
 
 
 
seems to be a primary regulator of GRC translocation.
We also examined Ca
 
2
 
 
 
 influx into resting hamster myo-
tubes. In BIO14.6 myotubes, Gd
 
3
 
 
 
-sensitive 
 
45
 
Ca
 
2
 
 
 
 uptake
was significantly greater compared with the controls and was
markedly suppressed by ruthenium red or SK&F96365, but
not by nifedipine (Fig. 3 a). On the other hand, when we el-
evated the external Ca
 
2
 
 
 
 acutely from 0.5 to 2 mM, [Ca
 
2
 
 
 
]
 
i
 
,
as monitored by the fluo-4 fluorescence, increased signifi-
cantly in BIO14.6 myotubes. SK&F96365 (Fig. 3 b), but
not nifedipine (0.1 
 
 
 
M; unpublished data), inhibited the in-
crease. In normal myotubes, 2 mM of external Ca
 
2
 
 
 
 induced
little change in fluo-4 fluorescence (Fig. 3 b). Of note, we
obtained similar results when [Ca
 
2
 
 
 
]
 
i
 
 was monitored using
the ratiometric dye fura-2 in place of fluo-4.
The efflux of creatine phosphokinase (CK) from myotube
cytoplasm can be regarded as an indicator of myocyte dam-
age. When we applied a cyclic cell stretch of 20% elongation
for 1 h in 2 mM Ca
 
2
 
 
 
, BIO14.6 myotubes released a high
level of CK (
 
 
 
30% of the total cell activity). Normal myo-
tubes released little CK activity, although the total cell activ-
ity of normal and myopathic myotubes did not differ. Prior
Figure 3. Increased Ca
2  influx into and CK efflux from BIO14.6 myotubes and their correction by  -SG gene transfer. (a) 
45Ca
2  uptake 
into normal or BIO14.6 myotubes measured under resting conditions with or without SK&F96365 (SK&F), ruthenium red (RR), or Nifedipine. 
The Gd
3 -inhibitable fractions are shown. (b) External Ca
2 -induced changes in fluo-4 fluorescence in normal or BIO14.6 myotubes. The bar 
graph shows the maximal increments of fluorescence in myotubes pretreated with or without 50  M SK&F96365.  F/F0 is the ratio between 
the fluorescence increment and the fluorescence before Ca
2  addition. Numbers in parentheses correspond to the number of cells studied. 
(c) CK efflux from BIO14.6 myotubes subjected to cyclic stretch under indicated conditions. (d) Immunoblot assay and immunohistochemistry 
(IH) of BIO14.6 myotubes infected with Ad. -gal or Ad. -SG. (e and f) External Ca
2 -induced changes in fluo-4 fluorescence and cyclic 
stretch–induced CK efflux in BIO14.6 myotubes insfected with Ad. -gal or Ad. -SG. TG, thapsigargin (1  M). Other conditions were similar 
to b and c. In these panels, error bars show means   SD and asterisks show P   0.05.T
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treatment of cells with SK&F96365 or ruthenium red, re-
ducing the external Ca
2  to 0.5 mM, or adding 0.5 mM
Ga
3  markedly suppressed CK efflux from BIO14.6 myo-
tubes (Fig. 3 c).
It should be noted that infection of the cells with an ade-
noviral vector carrying  -SG cDNA corrected all the above
abnormalities observed in BIO14.6 myotubes. Immunoblot
and immunohistochemical analyses revealed that elevated
sarcolemmal GRC levels were down-regulated in infected
myotubes, whereas  -SG and other DGC components were
expressed as in normal myotubes (Fig. 3 d; unpublished
data). Similarly,  -SG cDNA-infection of BIO14.6 myo-
tubes significantly suppressed the rise in fluo-4 fluorescence
in response to external Ca
2  addition (Fig. 3 e) and stretch-
induced CK efflux (Fig. 3 f).
We further examined whether GRC was involved in the
external Ca
2 -induced increase in [Ca
2 ]i or stretch-induced
CK efflux in BIO14.6 myotubes. Infection of BIO myo-
tubes with GRC antisense cDNA reduced the GRC protein
to 30–40% of the original level (Fig. 4 a). Immunostaining
with anti-GRC revealed markedly reduced expression of
GRC in the sarcolemma of treated myotubes, although
some still remained in the cell interior. Consistent with this
finding, a low level of GRC protein was labeled with mem-
brane-impermeable  N-hydroxysuccinimido-biotin (NHS-
biotin) applied from the outside. Importantly, both the rise
in [Ca
2 ]i and CK efflux during a 1-h stretch were signifi-
cantly suppressed in antisense DNA-treated BIO14.6 myo-
tubes (Fig. 4, b and c), strongly suggesting the involvement
of GRC in the observed abnormalities.
Properties of CHO cells expressing exogenous GRC
We used serum-starved CHO cells lacking endogenous GRC
to study the functional consequences of exogenous GRC sur-
face expression. GRC was predominantly localized in the cell
interior at rest, moving to the cell surface on 10% FCS addi-
tion (Fig. 5 a). IGF-I (10 ng/ml) or FCS induced [Ca
2 ]i to
rise slowly in these cells. No rise was observed in the presence
of 50  M Gd
3  or 50  M SK&F96365, which is consistent
with previous papers (Kanzaki et al., 1999; Boels et al., 2001).
Cyclic stretch of 10% elongation significantly enhanced
45Ca
2  uptake by GRC-transfected CHO cells, but not by
nontransfected cells (Fig. 5 b). It is noteworthy that 
45Ca
2 
uptake was significantly greater in GRC-transfected cells than
in nontransfected ones, even in the absence of stretch. Consis-
tent with these findings, a short stretch in 2 mM Ca
2  in-
Figure 4. Effect of GRC antisense expression on BIO14.6 myotubes. (a) Immunoblot assay for GRC and  -dystroglycan ( -DG; top) and 
GRC immunohistochemistry (middle) of BIO14.6 myotubes infected with Ad. -gal or Ad-antisense–GRC cDNA (Ad.asGRC). Cell surface 
GRC levels were estimated by labeling antisense-treated or nontreated myotubes with NHS-biotin and by further analyzing streptavidin 
agarose-bound (B) and -unbound (U) fractions by immunoblot assay with anti-GRC (bottom). (b and c) External Ca
2 -induced changes in 
fluo-4 fluorescence and cyclic stretch-induced CK efflux from antisense-treated or nontreated myotubes. Other conditions were the same as 
those in Fig. 3 (b and c). Error bars show means   SD and asterisks show P   0.05.T
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duced a transient rise in fluo-4 fluorescence only in GRC-
transfected cells cultured on an elastic silicone membrane,
which was inhibited by 50  M SK&F96365 (Fig. 5 c). These
results suggest that stretch enhanced Ca
2  influx via GRC.
Uniaxial cyclic stretch has been shown to induce human
umbilical vein endothelial cells to align perpendicularly to
the axis of stretch (Shirinsky et al., 1989). When we sub-
jected GRC-transfected CHO cells to 10% uniaxial stretch
at 1 Hz for 3 h, we observed enhanced stress fiber formation
as well as a shift in the cell orientation transverse to the
strain direction (Fig. 5 d). This orienting response, which we
observed only in GRC-transfected cells, became noticeable
after  90 min; it did not occur in the presence of 50  M
Gd
3  (unpublished data). Thus, it appears that stretch-depen-
dent Ca
2  influx via GRC is likely to cause cytoskeletal reor-
ganization in transfected CHO cells.
Transgenic mouse model of cardiac GRC overexpression
To examine the pathological consequences of GRC expres-
sion in vivo, we generated transgenic mice overexpressing
GRC in cardiac muscle (Fig. 6). Out of the four female and
seven male founders (F0s) obtained, three females died peri-
partum during their first pregnancy. These three F0s ex-
pressed the GRC protein at a level 10-fold of that of non-
transgenic controls, and had markedly elevated sarcolemmal
GRC (Fig. 6 a). Two of the males had two- to threefold
higher levels of GRC protein, as well as increased sarcolem-
mal GRC. These male F0s and a sterile female exhibited
prominent anasarca at the age of  180 d when we demon-
strated left ventricular dilation and compromised systolic
performance by M-mode echocardiography. Other male
founders exhibited normal levels of GRC protein and nor-
mal cardiac function, although they had at least a single copy
of the transgene.
The female F0s that died peripartum developed globally
enlarged hearts due to size increases of all four chambers
(Fig. 6 a). Also, the left ventricular wall and the septum were
mildly thickened compared with the nontransgenic controls.
Under light microscopy, the hearts exhibited a disorganized
myocyte arrangement, a pronounced increase in nonmyo-
Figure 5. Characterization of CHO cells expressing GRC. (a) Effect of FCS on GRC localization in CHO cells serum-starved for 24 h. Cells 
were stained with anti-GRC or rhodamine-phalloidin. (b) Gd
3 -inhibitable 
45Ca
2  uptake into GRC-transfected or nontransfected cells measured 
for 5 min with cyclic stretch applied for 3 min starting from the end of the first min. (c) Stretch–induced changes in [Ca
2 ]i as monitored by 
the fluo-4 fluorescence. The maximal increments of fluorescence are shown in the bar graph (mean   SD). Microscopic fields before and after 
stretch showing low and elevated levels of fluorescence in GRC-expressing cells (bottom). Data represent a typical result from four similar 
experiments. (d) Effect of uniaxial cyclic stretch on the cell orienting response. Rhodamine-phalloidin–stained images of nonstretched and 
stretched cells are shown. In b and c, error bars show means   SD and asterisks show P   0.05.T
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cyte space, and prominent interstitial fibrosis (Fig. 6 b). A
prominent feature revealed by EM was the disappearance of
Z bands in the myofibrils, with apparently preserved myofil-
ament alignment (Fig. 6 c). Mitochondria were also mark-
edly swollen.
The F1 offspring generated by mating a GRC-overex-
pressing male F0 (TG23) with normal female mice all died
perinatally. GRC protein in the hearts of these F1 mice was
threefold higher than that of their nontransgenic littermates,
and its level in the sarcolemma was also elevated (Fig. 6 d).
The hearts showed global enlargement affecting all four
chambers, and both atrial chambers were filled with orga-
nized thrombi (Fig. 6 d). Although few histological abnor-
malities were detected by light microscopy, ultrastructural
analysis of these F1 hearts often revealed partial disruption
of myofibrils along with irregularly spaced or markedly
shortened sarcomeres, perinuclear chromatin condensation,
and swollen mitochondria. In contrast, F1 offspring from
male F0s other than TG23 possessed normal levels of GRC
and few cardiac abnormalities were evident.
All of these morphological changes in female F0 and F1
mice were very similar to those seen in damaged cardiac
muscle under conditions in which cytosolic Ca
2  in myo-
cytes is greatly elevated (Reimer and Jenning, 1986). Consis-
tent with these alterations in cell structure, we found that a
large population of ventricular myocytes from GRC trans-
genic mice, i.e.,  40% (249 TUNEL-positive cells in 608
myocytes) in the TG19 female F0 and 18% (115 TUNEL-
positive cells in 628 myocytes) in the TG23 F1 mice, stained
positive in a TUNEL assay, suggesting the occurrence of ex-
tensive apoptosis. Together, these results suggest that a close
association exists between the level of GRC expression ver-
sus myocyte damage and loss of in vivo cardiac function in
GRC transgenic mice.
Discussion
Disruption of the DGC predisposes striated muscle cells to
progressive degeneration and contraction-induced damage.
Although the mechanism by which DGC disruption leads to
expression of the dystrophic phenotype has yet to be clari-
fied, accumulating evidence suggests that the muscle pathol-
ogy involves abnormal cell Ca
2  handling. Our findings pro-
vide evidence that abnormal Ca
2  influx is a key early event
in the pathogenesis of muscle degeneration caused by DGC
disruption.
Chronic elevation of [Ca
2 ] in the cytoplasm and other
intracellular compartments has been reported in the cases of
Figure 6. Histological analysis of GRC overexpressing transgenic hearts. (a) Hearts were excised from 120-d-old nontransgenic (WT) and 
transgenic (TG19 founder line) mice. (heart) Bar, 1 mm. (bottom) Immunoblot and immunohistochemical analyses of GRC protein in WT and 
TG19 ventricles. For the latter analysis, paraffin sections were used (left, WT; right, TG19). (b) Sections of heart from WT and TG19 mice 
stained with hematoxylin and eosin (left) or Masson’s trichrome (right). (c) Ultrastructural analysis of WT (left) and TG19 (right) ventricles. 
Z-lines are lost in TG19 (arrows). (d) Hearts excised from 1-d-old nontransgenic (WT) and transgenic (TG23F1) mice. (heart) Bar, 1 mm. 
(bottom) Immunoblot and immunohistochemical analyses of GRC protein in WT and TG23F1 ventricles. For the latter analysis, paraffin 
sections were used (left, WT; right, TG23F1). (e) Sections of ventricles from WT and TG23F1 mice stained with hematoxylin and eosin. 
(f) Ultrastructural analysis of WT (left) and TG23F1 (right) ventricles. Bars: (light microscopy) 50  m; (EM) 2  m. mt and N denote mitochondria 
and nuclei, respectively.T
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mdx skeletal fibers and cultured myotubes from dystrophin-
deficient DMD patients and mdx mice (Fong et al., 1990;
Brown and Lucy, 1997: Mallouk et al., 2000; Alderton and
Steinhardt, 2000b; Robert et al., 2001). This could be due
to increased Ca
2 -specific leak channel or mechanosensitive
cation channel basal activity, as has been demonstrated in
cultured myotubes from DMD patients, mdx mice, and
 -SG–deficient BIO14.6 hamsters (Fong et al., 1990; Franco-
Obregon and Lansman, 1994; Alderton and Steinhardt,
2000b; Nakamura et al., 2001; Vandebrouck et al., 2001).
In these dystrophic muscle preparations, elevated [Ca
2 ]i has
been causally linked to a greater rate of protein degradation
catalyzed by Ca
2 -dependent protease calpain (Turner et al.,
1988; MacLennan et al., 1991; Spencer et al., 1995; Alder-
ton and Steinhardt, 2000a), which with concurrent myocyte
contractile activity would cause physical damage to the sar-
colemma, leading to leakage of cytosolic enzymes such as
CK. Physical cell damage was indeed demonstrated in vitro
in isolated mdx fibers and in vivo in the muscle of dystrophic
patients (Mokri and Engel, 1975; Menke and Jockusch,
1991; Petrof et al., 1993). Dystrophic patients and animal
models also show consistently elevated CK levels in their se-
rum, although this is not always closely correlated with clin-
ical symptoms (Brown and Lucy, 1997).
In  -SG–deficient BIO14.6 myotubes, we detected ele-
vated basal activity of a nifedipine-insensitive, ruthenium
red– or SK&F96365-inhibitable Ca
2  influx as monitored
by an external Ca
2 -induced rise of the intracellular Ca
2 -
sensitive dye fluorescence or 
45Ca
2  uptake (Fig. 3, a and
b). We also observed efflux of high CK activity from
BIO14.6 myotubes in response to cyclic stretch under
conditions in which little efflux occurred from normal
myotubes (Fig. 3, c and f). The CK efflux was suppressed
by the Ca
2  influx inhibitors Gd
3 , ruthenium red, and
SK&F96365 (Fig. 3 c) or pretreatment of myotubes with
the calpain inhibitor E64 (Sampaolesi et al., 2001; un-
published data). Furthermore, adenoviral transfer of  -SG
cDNA to BIO14.6 myotubes caused significant reductions
in resting Ca
2  influx and stretch-induced CK efflux (Fig.
3, d–f). Hence, BIO14.6 myotubes seem to retain the origi-
nal phenotypes of dystrophic muscle. We have observed
similar cell abnormalities in myotubes prepared from the
rat L6 myoblasts or rat skeletal muscle that were rendered
deficient of sarcoglycans by treatment with antisense oligo-
nucleotides (Sampaolesi et al., 2001).
GRC is a Ca
2 -permeable nonselective cation channel be-
longing to the TRP channel family, which translocates from
the cell interior to the surface in response to growth factors
(Kanzaki et al., 1999; Boels et al., 2001). GRC is normally
expressed in adult striated muscles, with low expression in
the sarcolemma except in cardiac intercalated discs (Fig. 1).
In normal hamster myotubes, sarcolemmal GRC expression
was transiently elevated only on the first day of cell fusion,
whereas in BIO14.6 myotubes, this initial expression con-
tinued (Fig. 2; unpublished data). Intriguingly, in normal
myotubes, cell stretch increased sarcolemmal GRC expres-
sion, which required entry of external Ca
2  (Fig. 2, b and c).
This triggering Ca
2  could have entered via a low level of
GRC initially present in the sarcolemma. However, little is
known as to what initially triggers the surface translocation
of GRC during the formation of myotubes. The situation
was somewhat similar in the case of GRC-transfected CHO
cells; an applied stretch enhanced Ca
2  influx into the trans-
fected cells, which was blocked by Gd
3 , ruthenium red, or
SK&F96365 (Fig. 5; Results). Although these inhibitors are
not specific for GRC (Boels et al., 2001), the enhanced Ca
2 
influx was not observed in cells without GRC. Furthermore,
GRC-transfected CHO cells exhibited changes in cell orien-
tation and cytoskeletal organization in response to a rela-
tively long stretch, which appears to be mediated by Gd
3 -
inhibitable Ca
2  influx via GRC (Fig. 5).
Importantly, sarcolemmal GRC was elevated in skeletal
muscles from human patients with muscular dystrophy,
BIO14.6 hamsters, and mdx mice (Fig. 1, b and c). It also
increased in the sarcolemma of BIO14.6 cardiac muscle, but
not in mdx cardiac muscle, in which little dystrophic dam-
age occurs (Torres and Duchen, 1987). In BIO14.6 myo-
tubes, re-expression of  -SG protein by gene transfer mark-
edly reduced sarcolemmal GRC, abnormal Ca
2  influx, and
stretch-induced CK efflux (Fig. 3, d–f). Similarly, reduction
of sarcolemmal GRC by treatment with GRC antisense
cDNA decreased Ca
2  influx and CK efflux in BIO14.6
myotubes (Fig. 4). These results, together with the func-
tional properties of GRC discussed in the preceding para-
graph, strongly suggest that the sarcolemmal GRC level and
expression of dystrophic phenotypes are causally linked. A
recent paper has implicated TRPC subfamily members of
TRP channels in voltage-independent Ca
2  channel activity
in mdx fibers, based on inhibition of the latter by antisense
oligonucleotides with sequences conserved in all TRPC
channel isoforms (Vandebrouck et al., 2002). Although
GRC belongs to a different subfamily, it could also be an
antisense target.
The in vivo pathological consequence of GRC expression
in the sarcolemma may be inferred from cardiac abnormali-
ties observed in GRC transgenic mice (Fig. 6). Female
founders died peripartum during their first pregnancy,
whereas F1 mice from TG23 line all died perinatally. These
mice exhibited globally enlarged hearts and extensive myo-
cyte damage, with strong indications of apoptosis (Results).
Similar cell abnormalities are typically seen in Ca
2 -over-
loaded cardiac muscle (Reimer and Jenning, 1986) and,
though not as extensively, in some necrotic areas of dystro-
phic skeletal muscles from DMD patients and mdx mice
(Cullen and Fulthorpe, 1975; Cullen and Jaros, 1988). Fur-
thermore, the results obtained with these transgenics suggest
that there is a correlation between GRC expression, myocyte
damage, and the loss of cardiac function (Fig. 6; Results). It
seems likely that elevated levels of sarcolemmal GRC result
in greater Ca
2  influx in response to mechanical stress in the
cardiac chamber walls, causing further mobilization of GRC
on the cell surface, thereby exacerbating Ca
2  overloading
and the resultant cell damage.
GRC was originally identified as a Ca
2 -permeable cation
channel activated by IGF-1 and other growth factors (Kan-
zaki et al., 1999). IGF-1 is thought to be an important me-
diator of anabolic pathways in skeletal myocytes, playing a
critical role in myocyte proliferation, differentiation, and re-
generation after injury (Stewart and Rotwein, 1996). Skele-
tal muscle-specific expression of IGF-1 in transgenic mdxT
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mice has been shown to counter muscle decline by promot-
ing hypertrophy and hyperplasia of myocytes while prevent-
ing apoptosis (Barton et al., 2002). Furthermore, it has been
reported that IGF-1 improves cardiac performance in exper-
imental cardiac failure (Duerr et al., 1995). However, long-
term exposure of cardiac muscle to IGF-1 in a transgenic
mouse model resulted in decreased systolic performance and
marked interstitial fibrosis, suggesting the potentially delete-
rious effects of high levels of IGF-1 on the muscle function
(Delaughter et al., 1999). IGF-1 most likely activates multi-
ple signaling pathways in myocytes, with GRC being one of
its downstream targets. However, how GRC is involved in
the overall function of IGF-1 is currently unclear.
In summary, the data suggest that abnormal Ca
2  influx
and the resultant cell damage occur via GRC in  -SG–defi-
cient hamster muscle. GRC is likely to function in a similar
manner in dystrophin-deficient humans and mice. Because
mechanical stress enhances GRC-mediated Ca
2  influx, it is
important to examine whether GRC also plays a critical role
in the initiation or progression of other skeletal and/or car-
diac myopathies of genetic or nongenetic origin.
Materials and methods
Preparation of tissues and primary myotube culture
We used male BIO14.6 hamsters (SLC Japan; Nakamura et al., 2001) and
male mdx mice (Jackson Laboratories) 5–8 wk old and age-matched con-
trols. We obtained biopsy samples of the vastus lateralis muscle from pa-
tients after their informed consent. We prepared satellite cells from the gas-
trocunemius muscle of hamsters or mice by enzymatic dissociation as
described by Rando and Blau (1994), except that the initial enzyme cock-
tail for cell dissociation contained 0.5 mM CaCl2, instead of 2.5 mM, and
Ham’s F12 medium supplemented with 20% FCS, 2.5 ng/ml bFGF
(Promega), and 1% chick embryo extract (GIBCO BRL) was used for ham-
ster myoblasts. After enrichment of the myoblasts by several preplatings,
we changed the medium to DME containing 2% horse serum to induce
myotube formation. We performed experiments using myotubes cultured
for 2–4 d (for hamster) and  10 d (for mouse) after the start of fusion.
cDNA cloning and expression in cells
For cloning of GRC, we amplified cDNAs prepared from mouse heart to-
tal RNA by PCR using degenerated forward and reverse primers corre-
sponding to aa 596–601 and aa 698–703 of mouse GRC (Kanzaki et al.,
1999), respectively, which are conserved in rat VR1 (Caterina et al.,
1997) and a mouse stretch–inhibitable channel (Suzuki et al., 1999). Am-
plification conditions consisted of incubation at 94 C for 30 s, 52 C for
30 s, and 72 C for 30 s for a total of 25 cycles. Subsequent low stringency
screening (hybridization, 30% formamide at 48 C; washing, 2  SSC and
0.1% SDS at 55 C) of a mouse heart cDNA library (Stratagene) with the
PCR product from GRC permitted the isolation of many clones, but did
not produce any related to TRP channels except GRC. We tagged GRC
cDNA with a hemagglutinin epitope and subcloned it into the pIRES ex-
pression vector (Invitrogen), which we transfected into CHO-K1 cells and
selected with puromycin.
For adenoviral gene transfer, we ligated full-length cDNA of hamster
 -SG or  -galactosidase ( -gal), or full-length antisense cDNA of mouse
GRC into the Adeno-X
TM viral vector (CLONTECH Laboratories, Inc.) ac-
cording to the manufacturer’s protocol. We infected 1-d-old myotubes in
differentiated medium with adenoviruses at a multiplicity of infection of
5–10 viral particles per cell for 24 h and cultured them for an additional
36–48 h.
Generation of transgenic mice
We constructed the transgene by inserting full-length mouse GRC cDNA
between the mouse  -MHC promoter and the SV40 polyadenylation se-
quence of the plasmid (provided by Dr. J. Robbins, The Children’s Hospital
Research Foundation, Cincinnati, OH). We microinjected the transgene
into the male pronucleus of fertilized eggs from C57BL/6 mouse, which
was implanted into pseudopregnant foster mothers. We identified positive
transgenic mice either by Southern blotting or PCR detection of the trans-
gene. For PCR detection of the transgene, sense and antisense primers spe-
cific for the  -MHC gene and a coding region of mouse GRC were used.
Transgenic founders were mated with wild-type C57BL/6 mice to generate
F1 offspring.
Examination of histology, ultrastructure, and TUNEL-positive cells
We fixed hearts of transgenic mice in PBS containing 10% formalin and
embedded them in paraffin. We stained serial 5- m sections of samples
from the free wall of the left ventricles with hematoxylin/eosin or Masson’s
trichrome to evaluate gross morphology and fibrosis. For ultrastructural
analysis, we fixed and dehydrated samples according to the standard
method, and viewed the sections through a transmission microscope
(model H7000; Hitachi). We assayed TUNEL-positive cells using an apop-
tosis detection kit (Takara Biomedical) essentially as described previously
(Saito et al., 2000). The number of TUNEL-labeled nuclei was counted by
observing specimens from the TG19 female F0 and three TG23 F1 mice
and their normal controls with a light microscope (40  objective; Olym-
pus). TUNEL-positive cells were  3% in normal mouse ventricles.
Antibodies, immunoblotting, and immunohistochemistry
We raised polyclonal anti-GRC or anti– -SG antibody by immunizing rab-
bits or chickens with GST fusion proteins containing aa 634–756 of mouse
GRC protein or aa 1–32 of hamster  -SG, respectively. We affinity-purified
these antibodies as described previously (Bertrand et al., 1994). Other anti-
bodies used were described previously (Iwata et al., 1996; Yoshida et al.,
1998) or obtained commercially (antidystrophin NCL-Dys-1, -2, and -3;
Novocastra Laboratories). We performed immunoblot and immunohis-
tochemical analyses as described previously (Yoshida et al., 1998; Sampa-
olesi et al., 2001).
45Ca
2  uptake and [Ca
2 ]i measurement
We measured 
45Ca
2  uptake into cells cultured on collagen I–coated 24-
well dishes or silicon membranes at 37 C for 5 min in balanced salt solu-
tion (mM: 146 NaCl, 4 KCl, 2 MgCl2, 1 
45CaCl2, 10 glucose, 10 Hepes/Tris,
pH 7.4, and 0.1% BSA) containing 0 or 0.5 mM GdCl3 (Sampaolesi et al.,
2001). The Gd
3 -inhibitable fraction of 
45Ca
2  uptake was calculated by
subtracting the uptake in the presence of Gd
3  from that in its absence.
To monitor changes in [Ca
2 ]i, we loaded cells cultured on a cover glass
with 4  M fluo-4 acetoxymethyl ester at 37 C for 30 min in balanced salt
solution containing 0.5 mM Ca
2 . We observed fluorescence signals from
the cells at room temperature ( 25 C) using a confocal microscope
(model MRC-1024; Bio-Rad Laboratories) mounted on an microscope
(model BX50WI; Olympus) with a plan-apochromat 60  water immersion
lens. An argon laser was used to excite fluo4 at 488 nm. We acquired im-
ages at a rate of one image every second and used LaserSharp software
(Bio-Rad Laboratories) to analyze single frames or the single cell–inte-
grated signal density. In some experiments, we loaded cells with 2  M
fura-2 acetoxymethyl ester in place of fluo-4 acetoxymethyl ester and mea-
sured [Ca
2 ]i by means of a ratiometric fluorescence method, using a fluo-
rescence image processor (model Argus 50; Hamamatsu Photonics)
mounted on an inverted microscope (40  objective; Nikon). The excita-
tion wavelengths of 340 and 380 nm were alternated at 1 Hz, and the fluo-
rescence light emitted at 510 nm was measured. The fluorescence ratio
R340/380 was calculated and [Ca
2 ]i was determined using a Kd of 224 nM
for the dissociation of fura-2–Ca
2  complex (Grynkiewicz et al., 1985).
Application of stretch to cells
We applied a uniaxial sinusoidal stretch of up to 120% to cells at 1 Hz and
25 C using a temperature-controlled stretching apparatus (model NS-300;
SCHOLAR-TEC Co.) driven by a computer-controlled stepping motor, as
described previously (Naruse et al., 1998). We cultured the cells in a sili-
con chamber with 400- m-thick side walls and a 200- m-thick transpar-
ent bottom coated with collagen I. In this way, uniform stretch was applied
to most of cells cultured on the bottom (Naruse et al., 1998). To observe
the effect of stretch on cell [Ca
2 ]i response, the stretching apparatus was
modified for use on a microscope, which allowed the silicone chamber to
be placed on a confocal laser scanning microscope.
Surface labeling with NHS-biotin
We performed surface labeling of GRC protein in myotubes with mem-
brane-impermeable NHS-biotin as described previously (Wakabayashi et
al., 2000). In brief, we treated myotubes with 1 mM NHS-biotin for 30 min
at room temperature, solubilized with the lysis buffer (1% Triton X-100,
150 mM NaCl, 20 mM Hepes/Tris, pH 7.4, 0.1% SDS, 1% sodium deoxy-T
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cholate, 1 mM benzamidine, 0.25 mM phenylmethylsulfonyl flouride, and
2.5   g/ml aprotinin), and incubated for 1 h with streptavidin–agarose
beads. After washing, the proteins were released from the beads by boiling
in 3% SDS buffer and subjected to immunoblotting with anti-GRC.
Other procedures and materials
We determined CK activity in medium using an in vitro colorimetric assay
kit (Wako Chemicals) according to the manufacturer’s instruction (Sampa-
olesi et al., 2001). Protein concentration was measured using a bicin-
choninic acid assay system (Pierce Chemical Co.) with BSA as a stan-
dard. Gadolinium chloride hexahydrate, IGF-1, and LY294002 were
purchased from Sigma-Aldrich. Thapsigargin was obtained from Calbio-
chem. SK&F96365 was obtained from BIOMOL Research Laboratories,
Inc., and ruthenium red was obtained from Wako Chemicals. NHS-biotin
and streptavidin-conjugated agarose were purchased from Pierce Chemi-
cal Co. Fluo-4AM was purchased from Molecular Probes and fura-2AM
was purchased from Dojin Chemicals. 
45CaCl2 was obtained from NEN
Life Science Products.
Statistical analysis
Data are presented as means   SD of three or four determinations unless
otherwise stated. We used the t test to make comparisons between two
groups. P   0.05 was considered significant.
This work was supported by Special Coordination Funds from the Ministry
of Education, Culture, Sports, Science and Technology of Japan and by a
grant for Promotion of Fundamental Studies in Health Science from the Or-
ganization of Pharmaceutical Safety and Research. Y. Katanosaka is a do-
mestic research fellow of the Japan Society for the Promotion of Science.
Submitted: 24 January 2003
Revised: 29 April 2003
Accepted: 29 April 2003
References
Alderton, J.M., and R.A. Steinhardt. 2000a. Calcium influx through calcium leak
channels is responsible for the elevated levels of calcium-dependent proteoly-
sis in dystrophic myotubes. J. Biol. Chem. 275:9452–9460.
Alderton, J.M., and R.A. Steinhardt. 2000b. How calcium influx through calcium
leak channels is responsible for the elevated levels of calcium-dependent pro-
teolysis in dystrophic myotubes. Trends Cardiovasc Med. 10:268–272.
Bajusz, E., F. Homburger, J.R. Baker, and P. Bogdonoff. 1969. Dissociation of fac-
tors influencing myocardial degeneration and generalized cardiocirculatory
failure. Ann. NY Acad. Sci. 156:396–420.
Barton, E.R., L. Morris, A. Musarao, N. Rosenthal, and H.L. Sweeney. 2002.
Muscle-specific expression of insulin-like growth factor 1 counters muscle
decline in mdx mice. J. Cell Biol. 157:137–147.
Bertrand, B., S. Wakabayashi, S. Ikeda, J. Pouysségur, and M. Shigekawa. 1994.
The Na
 /H
  exchanger isoform 1 (NHE1) is a novel member of the cal-
modulin-binding proteins. Identification and characterization of calmodu-
lin-binding sites. J. Biol. Chem. 269:13703–13709.
Boels, K., G. Glassmeier, D. Herrmann, I.B. Riedel, W. Hampe, I. Kojima, R.
Schwarz, and H.C. Schaller. 2001. The neuropeptide head activator induces
activation and translocation of the growth-factor-regulated Ca
2 -permeable
channel GRC. J. Cell Sci. 114:3599–3606.
Brown, S.C., and J.A. Lucy. 1997. Functions of dystrophin. In Dystrophin. Gene,
Protein and Cell Biology. S.C. Brown and J.A. Lucy, editors. Cambridge
University Press, Cambridge. 163–200.
Caterina, M.J., T.A. Rosen, M. Tominaga, A.J. Brake, and D. Julius. 1997. The
capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature.
389:816–824.
Caterina, M.J., T.A. Rosen, M. Tominaga, A.J. Brake, and D. Julius. 1999. A cap-
saicin-receptor homologue with a high threshold for noxious heat. Nature.
398:436–441.
Cullen, M.J., and J.J. Fulthorpe. 1975. Stages in fiber breakdown in Duchenne
muscular dystrophy. An electron-microscopic study. J. Neurol. Sci. 24:179–
200.
Cullen, M.J., and E. Jaros. 1988. Ultrastructure of the skeletal muscle in the X
chromosome-linked dystrophic (mdx) mouse. Comparison with Duchenne
muscular dystrophy. Acta Neuropathol. (Berl). 77:69–81.
Delaughter, M.C., G.E. Taffet, M.L. Fiorotto, M.L. Entman, and R.J. Schwartz.
1999. Local insulin-like growth factor I expression induces physiologic, then
pathologic, cardiac hypertrophy in transgenic mice. FASEB J. 13:1923–
1929.
Duerr, R.L., S. Huang, H.R. Miraliakbar, R. Clark, K.R. Chien, and J. Ross, Jr.
1995. Insulin-like growth factor-1 enhances ventricular hypertrophy and
function during the onset of experimental cardiac failure. J. Clin. Invest. 95:
619–627.
Fong, P.Y., P.R. Turner, W.F. Denetclaw, and R.A. Steinhardt. 1990. Increased
activity of calcium leak channels in myotubes of Duchenne human and mdx
mouse origin. Science. 250:673–676.
Franco-Obregon, A., Jr., and J.B. Lansman. 1994. Mechanosensitive ion channels in
skeletal muscle from normal and dystrophic mice. J. Physiol. 481:299–309.
Grynkiewicz, G., M. Poenie, and R.Y. Tsien. 1985. A new generation of calcium
indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:
3440–3450.
Iwata, Y., H. Nakamura, Y. Mizuno, M. Yoshida, E. Ozawa, and M. Shigekawa.
1993. Defective association of dystrophin with sarcolemmal glycoproteins in
the cardiomyopathic hamster heart. FEBS Lett. 329:227–231.
Iwata, Y., Y. Pan, H. Hanada, T. Yoshida, and M. Shigekawa. 1996. Dystrophin–
glycoprotein complex purified from hamster cardiac muscle. Comparison of
the complexes from cardiac and skeletal muscles of hamster and rabbit. J.
Mol. Cell. Cardiol. 28:2501–2509.
Kanzaki, M., Y.Q. Zhang, H. Mashima, H. Shibata, and I. Kojima. 1999. Translo-
cation of a calcium-permeable cation channel induced by insulin-like growth
factor-1. Nat. Cell Biol. 1:165–170.
MacLennan, P.A., A. McArdle, and R.H.T. Edwards. 1991. Effects of calcium on
protein turnover of incubated muscles from mdx mice. Am. J. Physiol. 260:
E594–E598.
Mallouk, N., V. Jacquemond, and B. Allard. 2000. Elevated subsarcolemmal Ca
2 
in mdx mouse skeletal muscle fibers detected with Ca
2 -activated K
  chan-
nels. Proc. Natl. Acad. Sci. USA. 97:4950–4955.
Menke, A., and H. Jockusch. 1991. Decreased osmotic stability of dystrophin-less
muscle cells from the mdx mouse. Nature. 349:69–71.
Mokri, B., and A.G. Engel. 1975. Duchenne dystrophy: electronic microscopic
findings pointing to a basic or early abnormality in the plasma membrane of
muscle fiber. Neurology. 25:1111–1120.
Montell, C., and L. Birnbaumer. 2002. The TRP channels, a remarkably func-
tional family. Cell. 108:595–598.
Nakamura, T.Y., Y. Iwata, M. Sampaolesi, H. Hanada, N. Saito, M. Artman, W.A.
Coetzee, and M. Shigekawa. 2001. Stretch-activated cation channels in skel-
etal muscle myotubes from sarcoglycan-deficient hamsters. Am. J. Physiol.
Cell Physiol. 281:C690–C699.
Naruse, K., T. Yamada, and M. Sokabe. 1998. Involvement of SA channels in ori-
enting response of cultured endothelial cells to cyclic stretch. Am. J. Physiol.
274:H1532–H1538.
Nigro, V., Y. Okazaki, A. Belsito, G. Piluso, Y. Matsuda, L. Politano, G. Nigro, C.
Ventura, C. Abbondanza, A.M. Molinari, et al. 1997. Identification of the
Syrian hamster cardiomyopathy gene. Hum. Mol. Genet. 6:601–607.
Ozawa, E., S. Noguchi, Y. Mizuno, Y. Hagiwara, and M. Yoshida. 1998. From
dystrophinopathy to sarcoglycanopathy: evolution of a concept of muscular
dystrophy. Muscle Nerve. 21:421–438.
Petrof, B.J., J.B. Shrager, H.H. Stedman, A.M. Kelly, and H.L. Sweeney. 1993.
Dystrophin protects the sarcolemma from stresses developed during muscle
contraction. Proc. Natl. Acad. Sci. USA. 90:3710–3714.
Rando, T.A., and H.M. Blau. 1994. Primary mouse myoblast purification, charac-
terization, and transplantation for cell-mediated gene therapy. J. Cell Biol.
125:1275–1287.
Reimer, K.A., and R.B. Jenning. 1986. Myocardial ischemia, hypoxia, and infarc-
tion. In The Heart and Cardiovascular System. H.A. Fozzard, E.H. Habor,
R. B. Jennings, A.M. Katz, and H.E. Morgan, editors. Raven Press, New
York. 1133–1202.
Robert, V., M.L. Massimino, V. Tosello, R. Marsault, M. Cantini, V. Sorrentino,
and T. Pozzan. 2001. Alteration in calcium handling at the subcellular level
in mdx myotubes. J. Biol. Chem. 276:4647–4651.
Saito, S., Y. Hiroi, Y. Zou, R. Aikawa, H. Toko, F. Shibasaki, Y. Yazaki, R. Nagai,
and I. Komuro. 2000.  -Adrenergic pathway induces apoptosis through cal-
cineurin activation in cardiac myocytes. J. Biol. Chem. 275:34528–34533.
Sampaolesi, M., Y. Yoshida, Y. Iwata, H. Hanada, and M. Shigekawa. 2001.
Stretch-induced cell damage in sarcoglycan-deficient myotubes. Pflugers
Arch. 442:161–170.
Shirinsky, V.P., A.S. Antonov, K.G. Birukov, A.V. Sobolevsky, Y.A. Romanov,
N.V. Kabaeva, G.N. Antonova, and V.N. Smirnov. 1989. Mechano-chemi-T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 Cation channel in myocyte degeneration | Iwata et al. 967
cal control of human endothelium orientation and size. J. Cell Biol. 109:
331–339.
Spencer, M.J., D.E. Croall, and J.G. Tidball. 1995. Calpains are activated in ne-
crotic fibers from mdx dystrophic mice. J. Biol. Chem. 270:10909–10914.
Stewart, C., and P. Rotwein. 1996. Growth, differentiation, and survival: multiple
physiological functions for insulin-like growth factors. Physiol. Rev. 76:
1005–1026.
Straub, V., and K.P. Campbell. 1997. Muscular dystrophies and the dystrophin-
glycoprotein complex. Curr. Opin. Neurol. 10:168–175.
Suzuki, M., J. Sato, K. Kutsuwada, G. Ooki, and M. Imai. 1999. Cloning of a stretch-
inhibitable nonselective cation channel. J. Biol. Chem. 274:6330–6335.
Torres, L.F., and L.W. Duchen. 1987. The mutant mdx: inherited myopathy in
the mouse. Morphological studies of nerves, muscles and end-plates. Brain.
110:269–299.
Towbin, J.A., and N.E. Bawles. 2002. The failing heart. Nature. 415:227–233.
Turner, P.R., T. Westwood, C.M. Regen, and R.A. Steinhardt. 1988. Increased
protein degradation results from elevated free calcium levels found in muscle
from mdx mice. Nature. 335:735–738.
Tutdibi, O., H. Brinkmeier, R. Rudel, and K.J. Föhr. 1999. Increased calcium en-
try into dystrophin-deficient muscle fibers of MDX and ADR-MDX mice is
reduced by ion channel blockers. J. Physiol. 515:859–868.
Vandebrouck, C., G. Dupont, C. Cognard, and G. Raymond. 2001. Cationic chan-
nels in normal and dystrophic myotubes. Neuromuscul. Disord. 11:72–79.
Vandebrouck, C., D. Martin, M. Colson-Van Schoor, H. Debaix, and P. Gailly.
2002. Involvement of TRPC in the abnormal calcium influx observed in
dystrophic (mdx) mouse skeletal muscle fibers. J. Cell Biol. 158:1089–1096.
Wakabayashi, S., T. Pang, X. Su, and M. Shigekewa. 2000. A novel topology
model of the human Na
 /H
  exchanger isoform 1. J. Biol. Chem. 275:
7942–7949.
Yoshida, T., Y. Pan, H. Hanada, Y. Iwata, and M. Shigekawa. 1998. Bidirectional
signaling between sarcoglycans and the integrin adhesion system in cultured
L6 myocytes. J. Biol. Chem. 273:1583–1590.